Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (FcγRIII) expressed by human natural killer (NK) cells-Reference-Cited by-同舟云学术

Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (FcγRIII) expressed by human natural killer (NK) cells

Published:2008-03-12 Issue:4 Volume:89 Page:712-718
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Silla Lucia M. R.,Chen Jian,Zhong Rui-kun,Whiteside Theresa L.,Ball Edward D.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1995.tb08406.x/fullpdf

Reference31 articles.

1. Interleukin 2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: feasibility of LAK generation in adult patients with active disease and in remission;Adler;Blood,1988

2. The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not their precursors;Andrews;Blood,1986

3. Interleukin-2 with or without lymphokine-activated killer cells as consolidative immunotherapy after autologous bone marrow transplantation for acute myelogenous leukemia;Benyunes;Bone Marrow Transplantation,1993

4. Treatment of acute myeloid leukemia cells in vitro with monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed;Berstein;Journal of Clinical Investigation,1987

5. Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study;Bolhuis;International Journal of Cancer,1992

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK cell defects: implication in acute myeloid leukemia;Frontiers in Immunology;2023-05-09

2. NK cells in the tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends;Seminars in Immunology;2020-04

3. Antibody Therapies for Acute Myeloid Leukemia: Unconjugated, Toxin-Conjugated, Radio-Conjugated and Multivalent Formats;Journal of Clinical Medicine;2019-08-20

4. Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells;Antibodies;2019-07-03

5. Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy;Seminars in Immunology;2017-06